SourceWatch needs your financial support to survive and thrive. If you've found this information on the people, organizations, and issues shaping the public agenda helpful, please make a tax-deductible donation now.

From SourceWatch

Lipitor is a cholesterol lowering drug made by Pfizer.

In September 2008, Pfizer resumed advertising for its cholesterol drug Lipitor. In February 2008, the drugmaker pulled its Lipitor ads, over charges they were misleading. The old ads featured artificial heart inventor Robert Jarvik, who appeared to be giving medical advice though he isn't a practicing physician. The new ads feature "John E.," a baby boomer and heart-attack survivor who "didn't take a cholesterol-fighting drug before his heart attack ... despite a history of high cholesterol." A Pfizer marketing executive said, "When we did testing with consumers ... John really resonated with them." Pfizer is eager to maximize sales before its patent on Lipitor ends in 2011. ^[1]

Contents 1 Articles and resources 1.1 Related SourceWatch articles 1.2 References 1.3 External resources 1.4 External articles

Articles and resources

Related SourceWatch articles

• Direct-to-consumer advertising
• Drug industry
• Pfizer

References

1. ↑ Jon Kamp, "Pfizer Drops Celebrity Pitch in New Lipitor Spots: As Generics Catch Up, Dr. Jarvik Is Jettisoned From Heart-Drug Ads," Wall Street Journal (sub req'd), September 2, 2008.

External resources

External articles

• Ian Hall and Julia Hood, "Pfizer opens review for global Lipitor account", PR Week, October 5, 2006. (Sub req'd).
• Keith O'Brien, "Weber Shandwick nets global Lipitor business", PR Week, October 27, 2006. (Sub req'd).

This article is a stub. You can help by expanding it.